retatrutide eli lilly phase 2 results Shows Promising in Obesity and Diabetes Treatment | Mina Gereis posted on the topic Eli Lilly's New Weight-Loss Treatment

doi: 10.1038/nature05484

In: NCHS data brief, no 288 , vol

Zepbound targets weight loss by emulating the effects of GLP-1 and GIP hormones, crucial for appetite control and food intake regulation

To achieve the best possible outcomes, Zepbound should be combined with a balanced, reduced-calorie diet and regular physical activity

He has also co-authored Lasers in Aesthetic Surgery, which is considered a standard must-read textbook for aspiring plastic surgeons

Instead of prescribing an antidepressant that might cause weight gain (making one problem better while worsening the other), we can consider a low-dose GLP-1 that might help both while the patient engages in therapy and lifestyle changes